| abstract |
THE PRESENT INVENTION REFERS TO A VERY LOW DOSAGE DOSAGE FORM FOR HORMONAL REPLACEMENT THERAPY (HRT). MORE PARTICULARLY, THE PRESENT INVENTION REFERS TO A SOLID ORAL DOSAGE FORM THAT APPROXIMATELY APPROXIMATELY 0.5 MG AND 0, 25 MG OF DROSPIRENONE, AND AT LEAST ONE PHARMACEUTICALLY ACCEPTABLE EXCIPIENT. TO WEIGHT OF THE VERY LOW DOSE OF DRSP E2 AND SURPRISINGLY IT HAS BEEN FOUND THAT A HIGH PROPORTION OF WOMEN WHO SUFFER FROM MODERATE TO SERIOUS THINGS IN RESPONSE TO THESE THINGS. CONSEQUENCE, THE DOSAGE FORM OF THE INVENTION CAN BE USED AS A HORMONAL REPLACEMENT THERAPY OF MAINTENANCE OR CAN BE USED ALREADY WHEN THE HORMONAL REPLACEMENT THERAPY IS STARTED. |